Quick answer: Zepbound and Mounjaro are the same drug (tirzepatide) with different FDA approvals. Mounjaro is approved for diabetes. Zepbound is approved for weight loss. Your insurance usually decides which one you get.
Why Two Names for the Same Drug?
Eli Lilly makes both medications. They contain the exact same active ingredient: tirzepatide.
- Mounjaro: FDA-approved for type 2 diabetes
- Zepbound: FDA-approved for weight management
Same doses. Same pen device (with minor visual differences). Same manufacturer. Different label.
This matters because insurance follows FDA approvals. A plan may cover Mounjaro for diabetes but deny Zepbound for weight loss—or vice versa.
Quick Comparison
| Zepbound | Mounjaro | |
|---|---|---|
| Active drug | Tirzepatide | Tirzepatide |
| FDA approval | Weight management | Type 2 diabetes |
| Dose range | 2.5 mg – 15 mg | 2.5 mg – 15 mg |
| Injection frequency | Once weekly | Once weekly |
| Manufacturer | Eli Lilly | Eli Lilly |
| List price | ~$1,060/month | ~$1,060/month |
Weight Loss Results: Identical
Since both contain tirzepatide, weight loss results are the same:
- Average weight loss: 15-22% of body weight at max dose (15 mg)
- Timeline: 72 weeks in clinical trials
- Results vary: Some people lose more, some less
The SURMOUNT-1 trial showed 20.9% average weight loss for Zepbound at 15 mg over 72 weeks. Mounjaro shows similar results when used for weight loss.
Insurance Coverage: This Is Where They Differ
Most patients do not choose between Zepbound and Mounjaro based on preference. Insurance decides.
For weight loss
- Zepbound is FDA-approved for weight management, so plans that cover weight-loss medications typically cover Zepbound.
- Mounjaro is not approved for weight loss. Some doctors prescribe it off-label, but insurance often denies coverage without a diabetes diagnosis.
For diabetes
- Mounjaro is approved for type 2 diabetes and widely covered for that purpose.
- Zepbound is not approved for diabetes, so using it for blood sugar control would be off-label.
Medicare
Medicare Part D does not cover weight-loss medications. This means:
- Zepbound for weight loss: not covered
- Mounjaro for diabetes: may be covered
If you have Medicare and want tirzepatide for weight loss, you may need to pay cash or explore manufacturer programs.
Medicaid
Coverage varies by state. Some Medicaid programs cover GLP-1s for diabetes. Few cover them for weight loss alone.
Cost Comparison
Both medications have similar list prices and savings programs.
List price (without insurance)
- Zepbound: ~$1,060/month
- Mounjaro: ~$1,060/month
These are manufacturer list prices. Actual pharmacy prices may vary.
With savings card
Eli Lilly offers savings cards for both:
- Eligible patients: Commercial insurance, 18+, not on Medicare/Medicaid
- Cost: As low as $25/month
- Savings: Up to $550 per fill
You cannot use savings cards with Medicare, Medicaid, TRICARE, or other government insurance.
Without insurance
If you pay cash, compare prices at multiple pharmacies:
- Costco and warehouse pharmacies often have lower prices
- Some telehealth services bundle medication with visits
- 90-day supplies may cost less per month than 30-day refills
See our guide to GLP-1 cost without insurance for a detailed budgeting framework.
How to Get the Right One
Step 1: Check your insurance formulary
Call your insurance or check their website. Search for "tirzepatide" or the brand names. Look for:
- Prior authorization requirements
- Step therapy (trying other meds first)
- Quantity limits
- Diagnosis requirements
Step 2: Ask your doctor about the approved use
- If you have type 2 diabetes, ask about Mounjaro
- If you want weight loss and do not have diabetes, ask about Zepbound
Step 3: Get prior authorization if needed
Many plans require prior authorization. Your doctor's office submits clinical information to justify coverage. This can take days to weeks.
Step 4: Apply for the savings card
If you have commercial insurance, enroll in the manufacturer savings card:
Side Effects: Same for Both
Since they contain the same drug, side effects are identical:
- Nausea (most common)
- Decreased appetite
- Diarrhea or constipation
- Vomiting (less common)
- Stomach pain
- Fatigue
Side effects are strongest during the first few weeks and after dose increases. Most people adjust within 2-4 weeks.
Switching Between Zepbound and Mounjaro
If your insurance changes or you switch from diabetes treatment to weight loss (or vice versa), you can switch medications. Since doses are the same, your doctor can transfer your current dose.
Example: If you take Mounjaro 7.5 mg for diabetes and your insurance stops covering it, you might switch to Zepbound 7.5 mg if your plan covers Zepbound for weight loss.
Which Should You Choose?
You usually do not choose. Your insurance and diagnosis do.
| Your situation | Likely covered option |
|---|---|
| Type 2 diabetes | Mounjaro |
| Weight loss, no diabetes | Zepbound (if plan covers weight-loss meds) |
| Medicare + diabetes | Mounjaro (may be covered) |
| Medicare + weight loss only | Neither (pay cash) |
If your plan covers neither, talk to your doctor about:
- Other GLP-1 options (semaglutide/Wegovy)
- Manufacturer patient assistance programs
- Compounded tirzepatide (if available and appropriate)
Bottom Line
Zepbound and Mounjaro are the same medication with different FDA labels. Insurance coverage—not preference—usually determines which one you receive. Check your formulary, confirm your diagnosis matches the approved use, and apply for manufacturer savings if eligible.
Work with your healthcare provider to determine which medication is right for you. Insurance coverage and costs vary—verify with your plan and pharmacy.
Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication.
